Literature DB >> 34910265

Gender Minority Stress, Psychiatric Comorbidities, and the Experience of Migraine in Transgender and Gender-Diverse Individuals: a Narrative Review.

Anna Pace1, Mark Barber2, Jason Ziplow3, Jennifer A Hranilovich4, Eric A Kaiser5.   

Abstract

PURPOSE OF REVIEW: This review aims to discuss the experience of migraine in transgender and gender-diverse individuals as it relates to other psychiatric comorbidities such as anxiety, depression, PTSD, and others. As this population faces stigma and discrimination, literature posits that gender minority stress can also contribute to the experience of pain in these individuals. RECENT
FINDINGS: Though there is little explicit data on these topics, more recent studies have explored the concept of gender minority stress and how stigma and discrimination can affect health outcomes and overall perception of health. These findings, as well as data on psychiatric comorbidities in cisgender individuals with migraine, can be extrapolated to understand how gender minority individuals may experience migraine. Research has demonstrated that stigma and discrimination can affect health outcomes in the transgender and gender-diverse community. A recent study has shown that sexual minority stress associated with stigma, discrimination, and barriers to care can exacerbate migraine. It is known that psychiatric comorbidities such as anxiety, depression, and PTSD can affect migraine frequency and severity in cisgender individuals. Though there are no specific studies in the transgender and gender-diverse patient population, these highly prevalent mental health conditions could potentially contribute to their migraine experience. Hormones, as well, may affect mood in those on gender-affirming hormone therapy, with some studies exploring how this may have both a direct and indirect relationship with migraine. There are clear knowledge gaps that can be addressed by future research in these areas to better understand the migraine experience in transgender and gender-diverse individuals and improve overall care.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Gender minority stress; Gender-diverse; Headache; Hormones; Migraine; Stigma; Transgender

Mesh:

Year:  2021        PMID: 34910265     DOI: 10.1007/s11916-021-00996-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  6 in total

Review 1.  Barriers to healthcare for transgender individuals.

Authors:  Joshua D Safer; Eli Coleman; Jamie Feldman; Robert Garofalo; Wylie Hembree; Asa Radix; Jae Sevelius
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-04       Impact factor: 3.243

Review 2.  Gender identity disorder: a review of the past 10 years.

Authors:  S J Bradley; K J Zucker
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-07       Impact factor: 8.829

3.  Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study.

Authors:  Judith Bradford; Sari L Reisner; Julie A Honnold; Jessica Xavier
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

4.  What is the worst part about having epilepsy? A children's and parents' perspective.

Authors:  Amanda F Vanstraten; Yu-Tze Ng
Journal:  Pediatr Neurol       Date:  2012-12       Impact factor: 3.372

Review 5.  A Critical Exploration of Migraine as a Health Disparity: the Imperative of an Equity-Oriented, Intersectional Approach.

Authors:  Deanna R Befus; Megan Bennett Irby; Remy R Coeytaux; Donald B Penzien
Journal:  Curr Pain Headache Rep       Date:  2018-10-05

Review 6.  Gender dysphoria in adolescence: current perspectives.

Authors:  Riittakerttu Kaltiala-Heino; Hannah Bergman; Marja Työläjärvi; Louise Frisén
Journal:  Adolesc Health Med Ther       Date:  2018-03-02
  6 in total
  1 in total

1.  Migraine, Migraine Disability, Trauma, and Discrimination in Sexual and Gender Minority Individuals.

Authors:  Nicole Rosendale; Elan L Guterman; Juno Obedin-Maliver; Annesa Flentje; Matthew R Capriotti; Micah E Lubensky; Mitchell R Lunn
Journal:  Neurology       Date:  2022-07-11       Impact factor: 11.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.